NCT00528151View on ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

December 31, 2007

Conditions

Optic Atrophy, Hereditary, Leber

Interventions

DRUG

curcumin

curcumin 250 mg twice a day in the first group. placebo 1 capsule twice a day in the second group.

Trial Locations (1)

10700

Professor Wanicha Chuenkongkaew, Bangkok

All Listed Sponsors

lead

Mahidol University

OTHER

NCT00528151 - A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON) | Biotech Hunter | Biotech Hunter